Progress of targeted FOX family therapy in ovarian cancer
Ovarian cancer (OC) remains one of the most lethal malignancies affecting women, largely due to its asymptomatic onset and the consequent challenges in early detection and diagnosis. This often results in delayed treatment and poor clinical outcomes. Among gynecological cancers, OC exhibits the high...
Saved in:
| Main Authors: | Hairong Zhang, Cuiping Gong, Xin Lv |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1604998/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research progress on FOXM1 in ovarian cancer diagnosis and therapeutics
by: Xiao-Qing Tan, et al.
Published: (2025-06-01) -
AREG+ regulatory T cells mediating myocardial repair and neovascularization after myocardial infarction
by: Yan Wang, et al.
Published: (2025-06-01) -
FVTF inhibits hepatocellular carcinoma stem properties via targeting DNMT1/miR-34a-5p/FoxM1 axis
by: Xiao-Cheng Cao, et al.
Published: (2025-03-01) -
Fox – Fordyce Disease: a case report
by: Monika Rimdeikaite, et al.
Published: (2025-01-01) -
Ovarian cancer targeted therapy: current landscape and future challenges
by: Guangli Wang, et al.
Published: (2025-05-01)